Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bank of America
BAC
|
+$349M |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$305M |
| 3 |
iShares Gold Trust
IAU
|
+$282M |
| 4 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$269M |
| 5 |
Blackrock
BLK
|
+$267M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$625M |
| 2 |
NVIDIA
NVDA
|
+$604M |
| 3 |
Tesla
TSLA
|
+$576M |
| 4 |
Microsoft
MSFT
|
+$552M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$357M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 40.73% |
| 2 | Technology | 20.55% |
| 3 | Financials | 7.82% |
| 4 | Consumer Discretionary | 7.64% |
| 5 | Communication Services | 5.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5201
Cingulate
CING
$63.8M
| $1.27K | ﹤0.01% |
+311
| New | +$1.27K |
2025 Q2
0 quarters
|
|
5202
CALL
Estrella Immunopharma Warrant
ESLAW
| $1.24K | ﹤0.01% |
30,000
| – | – |
2023 Q4
6 quarters
|
|
5203
DELISTED
Akoya BioSciences
AKYA
| $1.21K | ﹤0.01% |
931
-18,647
| -95% | -$22.4K |
2023 Q2
8 quarters
|
|
5204
BRC Group Holdings
RILY
$188M
| $1.21K | ﹤0.01% |
407
-15,024
| -97% | -$46.2K |
2016 Q2
36 quarters
|
|
5205
Adial Pharmaceuticals
ADIL
$9.21M
| $1.2K | ﹤0.01% |
+159
| New | +$2.4K |
2025 Q2
0 quarters
|
|
5206
Regencell Bioscience
RGC
$4.72B
| $1.19K | ﹤0.01% |
+70
| New | +$854 |
2025 Q2
0 quarters
|
|
|
DRK
5207
DarkHorse Technologies Inc. Common Shares
DRK
$22.9M
| $1.19K | ﹤0.01% |
+201
| New | +$1.28K |
2025 Q2
0 quarters
|
|
5208
Velos Acquisition I Corp
VLOS
$253M
| $1.17K | ﹤0.01% |
+104
| New | +$1.15K |
2025 Q2
0 quarters
|
|
5209
One Stop Systems
OSS
$163M
| $1.17K | ﹤0.01% |
+330
| New | +$921 |
2025 Q2
0 quarters
|
|
5210
Cosmos Holdings
COSM
$33.9M
| $1.13K | ﹤0.01% |
+2,678
| New | +$1.13K |
2025 Q2
0 quarters
|
|
5211
BlackRock US Equity Factor Rotation ETF
DYNF
$42.2B
| $1.09K | ﹤0.01% |
+20
| New | +$1K |
2025 Q2
0 quarters
|
|
5212
InflaRx
IFRX
$212M
| $1.03K | ﹤0.01% |
1,301
| – | – |
2022 Q1
13 quarters
|
|
5213
Odyssey Marine Exploration
OMEX
$37.6M
| $1K | ﹤0.01% |
+851
| New | +$775 |
2025 Q2
0 quarters
|
|
5214
Mustang Bio
MBIO
$2.8M
| $961 | ﹤0.01% |
+1,006
| New | +$1.22K |
2025 Q2
0 quarters
|
|
5215
Intelligent Protection Management Corp
IPM
$22.4M
| $954 | ﹤0.01% |
+505
| New | +$970 |
2025 Q2
0 quarters
|
|
5216
LiveOne
LVO
$34.8M
| $932 | ﹤0.01% |
124
-5,102
| -98% | -$37.9K |
2024 Q1
5 quarters
|
|
5217
Firefly Neuroscience
AIFF
$17.3M
| $914 | ﹤0.01% |
+323
| New | +$1.02K |
2025 Q2
0 quarters
|
|
5218
DELISTED
Aptorum Group
APM
| $907 | ﹤0.01% |
995
+976
| +5,137% | +$920 |
2025 Q1
1 quarter
|
|
5219
Rekor Systems
REKR
$48.6M
| $899 | ﹤0.01% |
775
-52,783
| -99% | -$55.4K |
2023 Q3
7 quarters
|
|
5220
Victory Portfolios II VictoryShares Core Intermediate Bond ETF
UITB
$2.6B
| $894 | ﹤0.01% |
+19
| New | +$884 |
2025 Q2
0 quarters
|
|
5221
DELISTED
Society Pass
SOPA
| $886 | ﹤0.01% |
+642
| New | +$715 |
2025 Q2
0 quarters
|
|
5222
Xtrackers International Real Estate ETF
HAUZ
$1.01B
| $869 | ﹤0.01% |
38
| – | – |
2021 Q2
16 quarters
|
|
5223
iShares MSCI China A ETF
CNYA
$188M
| $861 | ﹤0.01% |
30
-15
| -33% | -$416 |
2021 Q1
17 quarters
|
|
5224
Jayud Global Logistics
JYD
$11.5M
| $841 | ﹤0.01% |
+83
| New | +$1.56K |
2025 Q2
0 quarters
|
|
5225
Solarmax Technology
SMXT
$24.5M
| $834 | ﹤0.01% |
64
-1,694
| -96% | -$23.1K |
2024 Q1
5 quarters
|
|
Similar funds
Citigroup's Q2 2025 Portfolio in Review
As of Q2 2025, Citigroup held 6,003 positions worth $204B, up 4.1% from $196B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Citigroup's Q2 2025 filing shows 467 new, 1,653 increased, 2,974 reduced and 377 closed positions. Its largest new stake was Amrize Ltd: 2,294,135 shares worth $114M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $625M.
By sector, the portfolio is most concentrated in Miscellaneous at 41% of assets, down from 44% a quarter earlier, followed by Technology and Financials.
- Citigroup's largest Q2 2025 buy was Amrize Ltd: 2,294,135 shares worth $114M.
- Citigroup added most to Bank of America in Q2 2025, an estimated $349M increase.
- Citigroup's biggest Q2 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $625M.
- Citigroup fully exited James Hardie Industries in Q2 2025, selling an estimated $125M.
- Citigroup's ten largest holdings make up 20% of its $204B portfolio in Q2 2025.
- Citigroup opened 467 new positions and closed 377 in Q2 2025.
- Citigroup's portfolio value rose 4.1% quarter-over-quarter to $204B.
Based on Citigroup's 13F filing for Q2 2025, filed 11 Aug 2025.